BioNTech Investor Day Presentation Deck slide image

BioNTech Investor Day Presentation Deck

Scaling up mRNA manufacturing 1 g - 350 g in early 2020 in late 2020 Marburg bulk mRNA batch size 10 in 2011 Batch-size and capacity expansion through Annual clinical patient batch capacity 1,000 10,000 > in 2022 Planned capacity digitalization and automation 1.4 kg in 2022 Manufacturing and automation BIONTECH 50
View entire presentation